Showing results (1-10 of 474) with videos related to

Sort By:
Pageof 48
Expert Opinion on Pharmacotherapy|December 18, 2014
Dapagliflozin therapy in type-2 diabetes: current knowledge and future perspectivesManfredi Rizzo, Noor Al-Busaidi, Ali A Rizvi
International Journal of Molecular Sciences|August 10, 2024
New Advances in Metabolic SyndromeManfredi Rizzo, Ali A Rizvi
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|April 12, 2022
The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk ReductionAli A Rizvi, Manfredi Rizzo
Medicina (Kaunas, Lithuania)|October 26, 2024
Age-Related Changes in Insulin Resistance and Muscle Mass: Clinical Implications in Obese Older AdultsAli A Rizvi, Manfredi Rizzo
International Journal of Molecular Sciences|November 27, 2021
Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future AvenuesAli A Rizvi, Andrej Janez, Manfredi Rizzo
Current Pharmaceutical Biotechnology|January 28, 2016
Incretins, Pregnancy, and Gestational DiabetesDragana Nikolic, Khalid Al-Rasadi, Noor Al Busaidi, et al.
Expert Opinion on Biological Therapy|July 22, 2015
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot studyAli A Rizvi, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Expert Opinion on Therapeutic Targets|May 23, 2013
Non-glycemic effects of pioglitazone and incretin-based therapiesManfredi Rizzo, Angelo Avogaro, Giuseppe Montalto, et al.
Medicina (Kaunas, Lithuania)|August 27, 2021
Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and CareAli A Rizvi, Anca Pantea Stoian, Nader Lessan, et al.
Biomedicines|November 27, 2021
Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical OptionsAli A Rizvi, Anca Pantea Stoian, Andrej Janez, et al.
Pageof 48